Atlas Trials

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Clinical trial NCT01268527 · COMPLETED

Trial details

NCT number
NCT01268527
Sponsor
Eisai Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2010-03-15
Primary completion
2010-12-11
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.